CardioFocus

CardioFocus is a leading medical device innovator focused on advancing ablation treatments for cardiac disorders, particularly atrial fibrillation (AFib), the most prevalent heart arrhythmia. With a commitment to improving patient outcomes, CardioFocus has developed the FDA-approved HeartLight Endoscopic Ablation System, a groundbreaking catheter ablation technology that combines direct visualization with titratable laser energy, setting a new benchmark for AFib ablation procedures.

CardioFocus's HeartLight System has successfully treated over 10,000 patients across the United States, Europe, and Japan, demonstrating its effectiveness and reliability in addressing complex cardiac conditions. Headquartered in Marlborough, MA, at 500 Nickerson Rd, Marlborough, MA 01752, US, CardioFocus continues to drive innovation in the medical device industry, offering solutions that enhance precision and efficacy in cardiac ablation.

CardioFocus is dedicated to transforming the landscape of cardiac arrhythmia treatment through cutting-edge technology and a steadfast commitment to patient care. By continually refining and advancing its HeartLight System, CardioFocus remains at the forefront of medical device innovation, providing healthcare professionals with the tools they need to deliver exceptional outcomes in AFib ablation. CardioFocus looks forward to expanding its reach and impact in the field of cardiac electrophysiology.

To the manager of CardioFocus, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative solutions.